ClassID:

169261

G01N33/57419 - page 3 - CPC Classification

Classification description:

Investigating or analysing materials by specific methods not covered by groups -; Biological material, e.g. blood, urine ; Haemocytometers; Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing; Immunoassay; Biospecific binding assay; Materials therefor for cancer; Specifically defined cancers of colon

Recent Application in this class:
#601
20120135399
2012-05-31

CANCER BIOMARKER AND METHODS OF USING THEREOF

#602
20120134997
2012-05-31

Polypeptides and polynucleotides, and uses thereof as a drug target for producing drugs and biologics

#603
20120134995
2012-05-31

METHOD FOR PREDICTING THE THERAPEUTIC RESPONSEIVENESS OF A PATIENT TO A MEDICAL TREATMENT WITH AN EGFR INHIBITOR

#604
20120129880
2012-05-24

Method for determining sensitivity to irinotecan and use thereof

#605
20120129200
2012-05-24

Prodefensin-A6 assay method for the in vitro diagnosis of colorectal cancer

#606
20120122112
2012-05-17

ANTIBODIES AS A CANCER DIAGNOSTIC

#607
20120114948
2012-05-10

Granules with reduced dust potential comprising an antifoam agent

#608
20120107838
2012-05-03

Cancer Diagnostics

#609
20120101003
2012-04-26

METHODS FOR THE DIAGNOSIS OR PROGNOSIS OF COLORECTAL CANCER

#610
20120094863
2012-04-19

BIOMARKERS AND METHODS FOR DETERMINING EFFICACY OF ANTI-EGFR ANTIBODIES IN CANCER THERAPY

#611
20120094291
2012-04-19

FCgamma POLYMORPHISMS FOR PREDICTING DISEASE AND TREATMENT OUTCOME

#612
20120094289
2012-04-19

Materials and methods for determining cancer risk

#613
20120093734
2012-04-19

PROTEIN-BASED METHODS AND COMPOSITIONS FOR THE DIAGNOSIS OF COLORECTAL ADENOCARCINOMA

#614
20120082618
2012-04-05

Prostate cancer diagnosis and treatment

#615
20120077750
2012-03-29

Use of a growth-stimulating protein

#616
20120076724
2012-03-29

Serpentine transmembrane antigens expressed in human cancers and uses thereof

#617
20120070853
2012-03-22

YKL-40 as a marker for gastrointestinal cancers

#618
20120070461
2012-03-22

Use of myeloid cell biomarkers for the diagnosis of cancer

#619
20120064101
2012-03-15

Compounds and methods useful for detection and treatment of cancer

#620
20120058131
2012-03-08

PTA089 PROTEIN

#621
20120052076
2012-03-01

Anti-trop-2 monoclonal antibodies and uses thereof in the treatment and diagnosis of tumors

#622
20120052071
2012-03-01

TUMOR MARKERS AND METHODS OF USE THEREOF

#623
20120046591
2012-02-23

Treatment devices and methods with extending elements

#624
20120046586
2012-02-23

Skin treatment devices and methods with pre-stressed configurations

#625
20120046186
2012-02-23

Gene Expression Markers for Prediction of Response to Platinum-Based Chemotherapy Drugs

#626
20120045775
2012-02-23

PHOSPHOSPECIFIC PAK ANTIBODIES AND DIAGNOSTIC KITS

#627
20120045439
2012-02-23

Tumor markers and methods of use thereof

#628
20120040842
2012-02-16

Gene expression markers for prediction of patient response to chemotherapy

#629
20120040355
2012-02-16

YKL-40 AS A MARKER FOR SELECTION OF TREATMENT AND MONITORING OF A DISEASE

#630
20120040354
2012-02-16

METHODS OF CLASSIFYING THE SEVERITY OF DISEASES OR DISORDERS

#631
20120040338
2012-02-16

RBM3 in Testicular Cancer Diagnostics and Prognostics

#632
20120039811
2012-02-16

Markers for cancer detection

#633
20120034218
2012-02-09

RBM3 in colorectal cancer prognostics

#634
20120028836
2012-02-02

Use of protein SATB2 as a marker for colorectal cancer

#635
20120028829
2012-02-02

ANTI-HEDGEHOG ANTIBODIES

#636
20120027799
2012-02-02

COMPOSITIONS AND METHODS FOR TREATING OR PREVENTING INFLAMMATORY BOWEL DISEASE AND COLON CANCER

#637
20120015847
2012-01-19

Diagnosis or prognosis of lung cancer and colorectal cancer based on expression level of glutaredoxin 3

#638
20110320392
2011-12-29

METHODS FOR PREDICTING CANCER RESPONSE TO EGFR INHIBITORS

#639
20110319289
2011-12-29

Molecular-based method of cancer diagnosis and prognosis

#640
20110318264
2011-12-29

Methods and compositions for diagnosis and treatment of cancer

#641
20110312511
2011-12-22

Multiplex Detection of Tumour Cells Using a Panel of Agents Binding to Extracellular Markers

#642
20110306055
2011-12-15

Method for Detecting Metastasis of GI Cancer

#643
20110296544
2011-12-01

COLON CANCER TARGETS AND USES THEREOF

#644
20110294148
2011-12-01

TISSUE INHIBITOR OF MATRIX METALLOPROTEINASES TYPE-1 (TIMP-1) AS A CANCER MARKER AND POSTOPERATIVE MARKER FOR MINIMAL RESIDUAL DISEASE OR RECURRENT DISEASE IN PATIENTS WITH A PRIOR HISTORY OF CANCER

#645
20110294130
2011-12-01

Anti-cancer drug screening method using RORα

#646
20110287958
2011-11-24

Method for Using Gene Expression to Determine Colorectal Tumor Stage

#647
20110287034
2011-11-24

THERAPEUTIC AND DIAGNOSTIC METHODS RELATING TO CANCER STEM CELLS

#648
20110281279
2011-11-17

CIRCULATING Epha2 RECEPTOR

#649
20110271357
2011-11-03

COLON DISEASE TARGETS AND USES THEREOF

#650
20110269158
2011-11-03

USE OF S-ERBB-3 AS A MARKER FOR CANCER

#651
20110269142
2011-11-03

Clinical Method for Individualized Epithelial Cancer Screening Involving ERCC5 and IGF2R Genetic Testing and Gene-Environment Interactions

#652
20110257034
2011-10-20

METHODS FOR IDENTIFYING GENES WHICH PREDICT DISEASE OUTCOME FOR PATIENTS WITH COLON CANCER

#653
20110256539
2011-10-20

Methods for Detecting Tumor Origin Based on MUC1, MUC2, and CK-17 Expression Levels

#654
20110251077
2011-10-13

Methods and Systems for Diagnosis of Non-Central Nervous System (CNS) Diseases in CNS Samples

#655
20110250228
2011-10-13

Compositions and Methods for Identifying and Targeting Cancer Cells of Alimentary Canal Origin

#656
20110246079
2011-10-06

INDIVIDUAL 5-FLUOROURACILE DOSE OPTIMIZATION IN FOLFOX TREATMENT

#657
20110237461
2011-09-29

USING PHAGE EPITOPES TO PROFILE THE IMMUNE RESPONSE

#658
20110237450
2011-09-29

Methods and systems of using exosomes for determining phenotypes

#659
20110236916
2011-09-29

METHODS AND MATERIALS FOR DETECTING COLORECTAL NEOPLASM

#660
20110224159
2011-09-15

BIDESMOSIDIC BETULIN AND BETULINIC ACID DERIVATIVES AND USES THEREOF AS ANTITUMOR AGENTS

#661
20110218379
2011-09-08

Epitopes derived from SATB2 and uses thereof

#662
20110217708
2011-09-08

Methods and compositions for detecting colon cancers

#663
20110201561
2011-08-18

TREATMENT OF METASTATIC COLON CANCER WITH B-SUBUNIT OF SHIGA TOXIN

#664
20110201512
2011-08-18

Biomarkers Indicative of Colon Cancer and Metastasis and Diagnosis and Screening Therapeutics Using the Same

#665
20110200597
2011-08-18

SIGNAL PATHWAY ALTERATIONS AND DRUG TARGET ELEVATIONS IN PRIMARY METACHRONOUS METASTATIC COLORECTAL CANCER COMPARED TO NON-METASTATIC DISEASE

#666
20110195849
2011-08-11

Methods and compositions for identifying inhibitors of MutSα or MutSβ interaction with MutLα

#667
20110195026
2011-08-11

Antibody drug conjugate treatment of colorectal cancer

#668
20110183859
2011-07-28

INFLAMMATORY GENES AND MICRORNA-21 AS BIOMARKERS FOR COLON CANCER PROGNOSIS

#669
20110183328
2011-07-28

Detecting neoplasm

#670
20110182892
2011-07-28

Methods to identify responsive patients

#671
20110177063
2011-07-21

Methods for treating colorectal cancer

#672
20110167505
2011-07-07

GFATS As Modifiers of the AXIN Pathway and Methods of Use

#673
20110165577
2011-07-07

SELECTION OF COLORECTAL CANCER PATIENTS FOR NEO-ADJUVANT AND ADJUVENT SYSTEMIC ANTI-CANCER TREATMENT

#674
20110165567
2011-07-07

Aberrant methylation of C6Orf150 DNA sequences in human colorectal cancer

#675
20110160287
2011-06-30

Potentiator of activity of anti-cancer agent and use thereof, and biomarker for prediction of prognosis in cancer patient and use thereof

#676
20110159509
2011-06-30

USE OF RUNX3 AND MIR-532-5P AS CANCER MARKERS AND THERAPEUTIC TARGETS

#677
20110158975
2011-06-30

USE OF RUNX3 AND MIR-532-5P AS CANCER MARKERS AND THERAPEUTIC TARGETS

#678
20110151460
2011-06-23

Methods and systems of using exosomes for determining phenotypes

#679
20110150877
2011-06-23

EPHRIN-B RECEPTOR PROTEIN INVOLVED IN CARCINOMA

#680
20110147218
2011-06-23

SOLUBLE CADHERIN 17 FOR THE DIAGNOSIS AND RISK STRATIFICATION OF CANCER AND TUMOR OF THE GASTROINTESTINAL TRACT

#681
20110129860
2011-06-02

CALPROTECTIN AND HEMOGLOBIN/HAPTOGLOBIN COMPLEX FROM STOOL SAMPLE TO ASSESS COLORECTAL CANCER

#682
20110129416
2011-06-02

Recombinant monoclonal antibodies and corresponding antigens for colon and pancreatic cancers

#683
20110124032
2011-05-26

Methods and Compositions for Treating Carcinoma Stem Cells

#684
20110117086
2011-05-19

Monoclonal antibodies to progastrin and their uses

#685
20110111434
2011-05-12

COLON STEM CELLS ASSOCIATED WITH COLITISAND COLORECTAL CANCER AND METHODS OF USE

#686
20110111421
2011-05-12

Gene expression markers for colorectal cancer prognosis

#687
20110110859
2011-05-12

Protein

#688
20110104701
2011-05-05

Protein disulfide isomerase assay method for the in vitro diagnosis of colorectal cancer

#689
20110104050
2011-05-05

Compositions and methods for identifying and targeting cancer cells of alimentary canal origin

#690
20110097759
2011-04-28

Gene expression markers for colorectal cancer prognosis

#691
20110097423
2011-04-28

Gene Prognosis Predictor Signature for Colorectal Carcinoma

#692
20110091895
2011-04-21

Immunoassays to detect diseases or disease susceptibility traits

#693
20110086349
2011-04-14

Proliferation Signatures and Prognosis for Gastrointestinal Cancer

#694
20110086064
2011-04-14

COMPOSITIONS AND METHODS FOR IDENTIFYING AND TARGETING CANCER CELLS OF ALIMENTARY CANAL ORIGIN

#695
20110081665
2011-04-07

Methods for making cancer prognoses based on subcellular localization of biomarkers

#696
20110076761
2011-03-31

Recombinant monoclonal antibodies and corresponding antigens for colon and pancreatic cancers

#697
20110064654
2011-03-17

Prostate cancer diagnosis and treatment

#698
20110060529
2011-03-10

TISSUE INHIBITOR OF MATRIX METALLOPROTEINASES TYPE-1 (TIMP-1) AS A CANCER MARKER

#699
20110060028
2011-03-10

COMBINATION THERAPY

#700
20110059464
2011-03-10

Biomarker Panel For Prediction Of Recurrent Colorectal Cancer

#701
20110059434
2011-03-10

P13K pathway mutations in cancer

#702
20110053217
2011-03-03

Polynucleotides encoding signal peptide-containing molecules

#703
20110053164
2011-03-03

Methods for determining cancer resistance to histone deacetylase inhibitors

#704
20110053149
2011-03-03

METHYLATION DETECTION IN THE GENOMIC REGION OF A RECEPTOR PROTEINTYROSINE PHOSPHATASE GAMMA GENE FOR DETECTION AND/OR DIAGNOSIS OF A TUMOUR

#705
20110044896
2011-02-24

Tumor-targeting monoclonal antibodies to FZD10 and uses thereof

#706
20110039272
2011-02-17

Gene expression markers for colorectal cancer prognosis

#707
20110039271
2011-02-17

Gene expression markers for colorectal cancer prognosis

#708
20110039270
2011-02-17

Gene expression markers for colorectal cancer prognosis

#709
20110039269
2011-02-17

Gene expression markers for colorectal cancer prognosis

#710
20110028533
2011-02-03

NOVEL FER -LIKE PROTEIN, PHARMACEUTICAL COMPOSITIONS CONTAINING IT AND METHOD FOR ITS USE

#711
20110027297
2011-02-03

Methods Involving MS4A12 and Agents Targeting MS4A12 for Therapy, Diagnosis and Testing

#712
20110009473
2011-01-13

PTTG1 as a biomarker for cancer treatment

#713
20100331249
2010-12-30

Pharmaceutical composition for inhibiting peritoneal dissemination

#714
20100330079
2010-12-30

Biomarker combinations for colorectal cancer

#715
20100325743
2010-12-23

Marks as modifiers of the p53 pathway and methods of use

#716
20100323367
2010-12-23

Method of detecting colon cancer marker

#717
20100317708
2010-12-16

Carcinoma diagnosis and treatment, based on ODC1 genotype

#718
20100316639
2010-12-16

BIOMARKERS FOR IGF-1R INHIBITOR THERAPY

#719
20100316616
2010-12-16

Use of FZC18-Containing Collagen 18 Polypeptides for the Treatment, Diagnosis and Outcome Prediction of Diseases

#720
20100311047
2010-12-09

Identification of cancer protein biomarkers using proteomic techniques

#721
20100304989
2010-12-02

Molecular profiling of tumors

#722
20100304410
2010-12-02

Method of assessing colorectal cancer status in an individual

#723
20100304374
2010-12-02

METHODS AND TOOLS FOR DISCRIMINATING COLORECTAL ADENOMAS AND ADENOCARCINOMAS

#724
20100297618
2010-11-25

METHODS FOR DETERMINING A PROGNOSIS OF COLORECTAL CANCER

#725
20100297134
2010-11-25

Humanised antibodies with anti-tumour activity

#726
20100297014
2010-11-25

METHOD OF DETECTING THE RISK OF CANCER USING GENETIC MARKERS

#727
20100292451
2010-11-18

METHOD FOR DIAGNOSING SELECTED ADENOCARCINOMAS

#728
20100292162
2010-11-18

SOCS-3 promoter methylation in cancer

#729
20100291581
2010-11-18

Aldehyde dehydrogenase 1 (ALDH1) as a cancer stem cell marker

#730
20100291567
2010-11-18

Genes and polypeptides relating to hepatocellular or colorectal carcinoma

#731
20100285980
2010-11-11

Gene expression profile algorithm and test for likelihood of recurrence of colorectal cancer and response to chemotherapy

#732
20100284989
2010-11-11

15-PGDH in colon cancer

#733
20100284918
2010-11-11

PROTEIN

#734
20100275275
2010-10-28

HADHs as Modifiers of the p21 Pathway and Methods of Use

#735
20100273668
2010-10-28

Use of an endoplasmin fragment and derivatives thereof as biomarker for colorectal adenoma and/or carcinoma; method for detection and test system

#736
20100273191
2010-10-28

Methods of diagnosing cancer

#737
20100261174
2010-10-14

Determination of 5-ASA efficacy in CRC prevention and/or treatment by gene expression analysis

#738
20100255503
2010-10-07

MARKERS FOR DIAGNOSIS OF CANCER AND ITS USE

#739
20100248234
2010-09-30

Cancer diagnostic kit and cancer diagnostic method

#740
20100247438
2010-09-30

IN VITRO METHOD FOR DIAGNOSING TUMOR DISEASES

#741
20100242124
2010-09-23

Compositions and methods for the treatment and prevention of ulcerative colitis and colon cancer and screening methods to identify same

#742
20100240081
2010-09-23

Method for providing diagnosis of cancer using seprase as a marker

#743
20100240068
2010-09-23

MARKER PANEL FOR COLORECTAL CANCER

#744
20100233712
2010-09-16

Method for early detection of cancers

#745
20100227319
2010-09-09

USE OF RUNX3 AND MIR-532-5P AS CANCER MARKERS AND THERAPEUTIC TARGETS

#746
20100221754
2010-09-02

Biomarkers and methods for determining sensitivity to epidermal growth factor receptor modulators

#747
20100216179
2010-08-26

Method for detecting cancer and reagents for use therein

#748
20100216156
2010-08-26

CANCER MARKERS

#749
20100209906
2010-08-19

Methods and compositions for detecting colon cancers

#750
20100203529
2010-08-12

Methods and systems of using exosomes for determining phenotypes

#751
20100202964
2010-08-12

Organ Homing Genes of Cancer Metastases

#752
20100190173
2010-07-29

Gene expression markers for colorectal cancer prognosis

#753
20100184099
2010-07-22

Reagents And Methods For Cancer Prognosis And Pathological Staging

#754
20100184088
2010-07-22

Methods of identifying agents that modulate methylation of VEGFR1 by SMYD3

#755
20100184065
2010-07-22

Method of Predicting Non-Response to First Line Chemotherapy

#756
20100184046
2010-07-22

Methods and systems of using exosomes for determining phenotypes

#757
20100183630
2010-07-22

Tat-005 and Methods of Assessing and Treating Cancer

#758
20100173320
2010-07-08

Methods for Detecting Nucleic Acids Indicative of Cancer

#759
20100172908
2010-07-08

METHODS AND COMPOSITIONS FOR TREATING DISEASES TARGETING MABA1

#760
20100166652
2010-07-01

Laminin receptor 1 precursor protein (37LRP) epitope delineated by an hepatocellular carcinoma specific antibody

#761
20100159479
2010-06-24

TIMP-1 AS A MARKER FOR COLORECTAL CANCER

#762
20100159470
2010-06-24

SCDs as modifiers of the p53 pathway and methods of use

#763
20100158856
2010-06-24

Assays and methods using biomarkers

#764
20100154071
2010-06-17

FXDY5 MODULATORS FOR TREATING, DIAGNOSING, AND DETECTING CANCER

#765
20100151456
2010-06-17

Method for the assay of liver fatty acid binding protein, ACE and CA 19-9 for the in vitro diagnosis of colorectal cancer

#766
20100150907
2010-06-17

PRO115 antibody compositions and methods of use

#767
20100150901
2010-06-17

26199, 33530, 33949, 47148, 50226, 58764, 62113, 32144, 32235, 23565, 13305, 14911, 86216, 25206, and 8843 molecules and uses therefor

#768
20100143949
2010-06-10

BIOMARKERS FOR COLORECTAL CANCER

#769
20100136572
2010-06-03

METHOD OF ASSAYING APOLIPOPROTEIN AI FOR THE IN VITRO DIAGNOSIS OF COLORECTAL CANCER

#770
20100136571
2010-06-03

I-Plastin assay method for the in vitro diagnosis of colorectal cancer

#771
20100136539
2010-06-03

Ezrin assay method for the in vitro diagnosis of colorectal cancer

#772
20100136017
2010-06-03

Diagnostic tumor markers, drug screening for tumorigenesis inhibition, and compositions and methods for treatment of cancer

#773
20100135991
2010-06-03

ANTIBODIES RECOGNIZING OXYGEN-REGULATED PROTEIN 150 EXPRESSED ON CANCER CELLS AND METHODS OF USING SAME

#774
20100130375
2010-05-27

Apolipoprotein AII assay method for the in vitro diagnosis of colorectal cancer

#775
20100129844
2010-05-27

Aminoacylase 1 assay method for the in vitro diagnosis of colorectal cancer

#776
20100129828
2010-05-27

Method of assaying leukocyte elastase inhibitor for the in vitro diagnosis of colorectal cancer

#777
20100124534
2010-05-20

Immunotherapeutic method

#778
20100119515
2010-05-13

Methods and compositions for modulating angiogenesis

#779
20100113328
2010-05-06

Targeted delivery to legumain-expressing cells

#780
20100112713
2010-05-06

Methods For Detecting Colorectal Diseases And Disorders

#781
20100111969
2010-05-06

IL-4 RECEPTOR AND IL-13 AS PROGNOSTIC MARKERS FOR COLON AND PANCREAS TUMORS

#782
20100105745
2010-04-29

Suppression of cancer and method for evaluating anticancer agent based on the effect of inhibiting gsk3 beta

#783
20100099086
2010-04-22

Method and apparatus for determining a probability of colorectal cancer in a subject

#784
20100098628
2010-04-22

PROTEINS

#785
20100098627
2010-04-22

PROTEINS

#786
20100098626
2010-04-22

Protein

#787
20100093552
2010-04-15

USE AND IDENTIFICATION OF BIOMARKERS FOR GASTROINTESTINAL DISEASES

#788
20100092578
2010-04-15

PROTEIN KINASE C IOTA

#789
20100075365
2010-03-25

Perinucleolar compartment as a cancer marker

#790
20100074895
2010-03-25

Method for detecting and controlling cancer

#791
20100069470
2010-03-18

IDENTIFICATION OF PROTEIN BIOMARKERS ASSOCIATED WITH LYMPH NODE METASTASIS IN COLORECTAL CANCER

#792
20100068731
2010-03-18

Use of N-myristoyltransferase on non-tumor tissue for cancer diagnosis

#793
20100068708
2010-03-18

Methods for Identifying Compounds that Modulate WNT Signaling in Cancer Cells

#794
20100062450
2010-03-11

Methods and kits for early detection of cancer or predisposition thereto

#795
20100062447
2010-03-11

Methods for Identifying Cancer Risk

#796
20100062005
2010-03-11

Methods and compounds for lymphoma cell detection and isolation

#797
20100048415
2010-02-25

METHOD FOR THE DETECTION OF INTERFERON-ASSOCIATED ANGIOSTATIC TUMORSTAGES IN COLORECTAL CARCINOMA

#798
20100047830
2010-02-25

COMPOSITIONS AND METHODS FOR DETECTING CANCERS IN A SUBJECT

#799
20100047240
2010-02-25

Metastasis specific splice variants of mena and uses thereof in diagnosis, prognosis and treatment of tumors

#800
20100041167
2010-02-18

DRUG FOR DIAGNOSING LARGE INTESTINAL CANCER AND/OR POLYP, OBSERVING POSTOPERATIVE COURSE AND MONITORING RECURRENCE

#801
20100041138
2010-02-18

Nucleic acids encoding IL-17 homologous receptor-like polypeptides and therapeutic uses thereof

#802
20100034821
2010-02-11

GENETIC VARIATIONS ASSOCIATED WITH TUMORS

#803
20100024049
2010-01-28

Digestive system cancer stem cells and tests and uses therefor

#804
20100022625
2010-01-28

Structural-based inhibitors of the glutathione binding site in aldose reductase, methods of screening therefor and methods of use

#805
20100016404
2010-01-21

Structural-based inhibitors of the glutathione binding site in aldose reductase, methods of screening therefor and methods of use

#806
20100015632
2010-01-21

METHOD FOR EXAMINING COLORECTAL CANCER AND COLORECTAL ADENOMA

#807
20100015167
2010-01-21

COMPOSITIONS AND METHODS FOR IDENTIFYING AND TARGETING CANCER CELLS OF ALIMENTARY CANAL ORIGIN

#808
20100015152
2010-01-21

Diagnostic and therapeutic methods

#809
20100009401
2010-01-14

Method, apparatus, system, program, and computer-readable recording medium for evaluating colorectal cancer

#810
20100009359
2010-01-14

Methods and compositions for detecting colon cancers

#811
20100003247
2010-01-07

ASSAY FOR METASTATIC COLORECTAL CANCER

#812
20100003239
2010-01-07

Anti-hedgehog antibodies

#813
20090325214
2009-12-31

NUCLEAR MATRIX PROTEIN ALTERATIONS ASSOCIATED WITH COLON CANCER AND THEIR USE AS MARKERS FOR COLORECTAL CANCER

#814
20090318672
2009-12-24

Antibodies to PRO352

#815
20090318340
2009-12-24

IL-17 homologous polypeptides and therapeutic uses thereof

#816
20090317810
2009-12-24

METHODS AND NUCLEIC ACIDS FOR THE DETECTION OF COLORECTAL CELL PROLIFERATIVE DISORDERS

#817
20090311726
2009-12-17

Methods and compositions for categorizing patients

#818
20090305277
2009-12-10

Gene expression markers for prediction of patient response to chemotherapy

#819
20090291447
2009-11-26

Method of detecting colon cancer marker

#820
20090291436
2009-11-26

METHODS FOR DETECTING NUCLEIC ACIDS INDICATIVE OF CANCER

#821
20090291434
2009-11-26

Gene expression markers for colorectal cancer prognosis

#822
20090286328
2009-11-19

USE OF PROTEIN S100A12 AS A MARKER FOR COLORECTAL CANCER

#823
20090286246
2009-11-19

Methods for Identifying Compounds that Affect Expression of Cancer-Related Protein Isoforms

#824
20090280493
2009-11-12

Methods and Compositions for the Prediction of Response to Trastuzumab Containing Chemotherapy Regimen in Malignant Neoplasia

#825
20090275633
2009-11-05

Novel Tumour Suppressor

#826
20090275546
2009-11-05

Diagnostic tests and personalized treatment regimes for cancer stem cells

#827
20090275057
2009-11-05

Diagnostic markers predictive of outcomes in colorectal cancer treatment and progression and methods of use thereof

#828
20090263399
2009-10-22

Method for establishing the sensitivity of tumours to capecitabin and test kit

#829
20090258795
2009-10-15

Gene expression markers for prediction of patient response to chemotherapy

#830
20090258364
2009-10-15

Method of determining the sensitivity of cancer cells to EGFR inhibitors including cetuximab, panitumumab and erlotinib

#831
20090258358
2009-10-15

Methods for Diagnosing and Treating Kidney and Colorectal Cancer

#832
20090258345
2009-10-15

PROTEIN ASSOCIATED WITH COLORECTAL CANCER, POLYNUCLEOTIDE INCLUDING SINGLE-NUCLEOTIDE POLYMORPHISM ASSOCIATED WITH COLORECTAL CANCER, MICROARRAY AND DIAGNOSTIC KIT INCLUDING THE SAME, AND METHOD OF DIAGNOSING COLORECTAL CANCER USING THE SAME

#833
20090239216
2009-09-24

Novel Tannase Gene And Protein Thereof

#834
20090238833
2009-09-24

PROTEIN

#835
20090238830
2009-09-24

PROTEIN

#836
20090233294
2009-09-17

UHRF1 DIRECTED DIAGNOSTICS FOR NEOPLASTIC DISEASE

#837
20090233293
2009-09-17

TTK DIRECTED DIAGNOSTICS FOR NEOPLASTIC DISEASE

#838
20090232821
2009-09-17

Use Of A Growth-Stimulating Protein

#839
20090232813
2009-09-17

Four-jointed box (FJX1) in cancer diagnosis and treatment

#840
20090232732
2009-09-17

Pro108 antibody compositions and methods of use and use of Pro108 to assess cancer risk

#841
20090227017
2009-09-10

NUCLEIC ACIDS ENCODING RECEPTOR FOR IL-17 HOMOLOGOUS POLYPEPTIDES AND USES THEREOF

#842
20090226935
2009-09-10

NUCLEAR MATRIX PROTEIN ALTERATIONS ASSOCIATED WITH COLON CANCER AND COLON METASTASIS TO THE LIVER, AND USES THEREOF

#843
20090226921
2009-09-10

Methods to detect tumors using 20P1F12/TMPRSS2 expression

#844
20090226905
2009-09-10

Diagnosis and prognosis of colorectal cancer

#845
20090220975
2009-09-03

Use of protein SATB2 as a marker for colorectal cancer

#846
20090220965
2009-09-03

Methods for prognosing the recurrence of gastrointestinal and other cancers using the Shc proteins

#847
20090215089
2009-08-27

Compositions and methods for identifying and targeting cancer cells of alimentary canal origin

#848
20090215063
2009-08-27

Phosphospecific PAK antibodies and diagnostic kits

#849
20090215046
2009-08-27

Novel nucleotide and amino acid sequences, and assays methods of use thereof for diagnosis of colon cancer

#850
20090214571
2009-08-27

Colon cancer related gene TOM34

#851
20090208411
2009-08-20

Cytotoxicity mediation of cells evidencing surface expression of CD44

#852
20090203024
2009-08-13

Secreted protein called 36P6D5 characteristic of tumors

#853
20090192193
2009-07-30

Method of treating colorectal carcinoma

#854
20090191575
2009-07-30

TUMOR MARKER AND METHOD FOR DETERMINATION OF THE OCCURRENCE OF CANCEROUS DISEASE

#855
20090181384
2009-07-16

Methods for treating colorectal cancer using prognostic genetic markers

#856
20090181016
2009-07-16

FCgamma POLYMORPHISMS FOR PREDICTING DISEASE AND TREATMENT OUTCOME

#857
20090170133
2009-07-02

Intact IGFBP-3 as a Colon Cancer Risk Factor in Patients With Inflammatory Bowel Disease

#858
20090170132
2009-07-02

Methods for detecting colon carcinoma

#859
20090169575
2009-07-02

PROTEINS

#860
20090163844
2009-06-25

Methods for the treatment or prevention of scars and/or keloids

#861
20090162931
2009-06-25

Recombinant monoclonal antibodies and corresponding antigens for colon and pancreatic cancers

#862
20090155842
2009-06-18

PROGNOSTIC ASSAY FOR METACHRONOUS COLORECTAL CANCER

#863
20090155820
2009-06-18

ASC as a marker for colorectal cancer

#864
20090148898
2009-06-11

Human Ron-related gene variant associated with cancers

#865
20090148897
2009-06-11

Human Ron-related gene variant associated with cancers

#866
20090148868
2009-06-11

JAB1 as a prognostic marker and a therapeutic target for human cancer

#867
20090148439
2009-06-11

Methods for diagnosis and treatment of epithelial-derived cancers

#868
20090142332
2009-06-04

Identification of biomarkers by serum protein profiling

#869
20090136920
2009-05-28

Diagnostics and therapeutics for diseases associated with serum/glucocorticoid regulated kinase 1 (sgk1)

#870
20090136508
2009-05-28

METHOD OF DIAGNOSING COLON AND GASTRIC CANCERS

#871
20090123949
2009-05-14

METHODS FOR DETERMINING THE PROGNOSIS FOR CANCER PATIENTS USING TUCAN

#872
20090123374
2009-05-14

Methods for determining cancer resistance to histone deacetylase inhibitors

#873
20090112120
2009-04-30

DRUG SCREENING AND MOLECULAR DIAGNOSTIC TEST FOR EARLY DETECTION OF COLORECTAL CANCER: REAGENTS, METHODS, AND KITS THEREOF

#874
20090075312
2009-03-19

ASSESSING COLORECTAL CANCER BY MEASURING OSTEOPONTIN AND CARCINOEMBRYONIC ANTIGEN

#875
20090075311
2009-03-19

ASSESSING COLORECTAL CANCER BY MEASURING HEMOGLOBIN AND M2-PK IN A STOOL SAMPLE

#876
20090074800
2009-03-19

Cancer antigen and use thereof

#877
20090061453
2009-03-05

Methods and compositions for detecting colon cancers

#878
20090054624
2009-02-26

PRO1190 polypeptides

#879
20090035794
2009-02-05

METHOD FOR DETECTING, SCREENING, AND/OR MONITORING CANCER IN AN INDIVIDUAL

#880
20090035303
2009-02-05

Methods of detecting methyl transferase activity and methods of screening for methyl transferase activity modulators

#881
20090035299
2009-02-05

Methods and compositions for treating diseases targeting MABA1

#882
20090028863
2009-01-29

MARKERS FOR DIAGNOSIS OF CANCER AND ITS USE

#883
20090011438
2009-01-08

Collagen VI and cancer

#884
20080311131
2008-12-18

Human Mob-5 (IL-24) receptors and uses thereof

#885
20080305558
2008-12-11

Cancer Screening Test

#886
20080299589
2008-12-04

Methods and Materials for Examining the P13k/Akt Pathway in Gliomas and Prostate Cancers

#887
20080286801
2008-11-20

Method for the analysis of differential expression in colorectal cancer

#888
20080286799
2008-11-20

Methods of and kits and compositions for diagnosing colorectal tumors

#889
20080267863
2008-10-30

Method of Diagnosing, Monitoring, Staging, Imaging and Treating Colon Cancer

#890
20080263684
2008-10-23

PIK4CA as modifier of the Rac pathway and methods of use

#891
20080261246
2008-10-23

TISSUE INHIBITOR OF MATRIX METALLOPROTEINASES TYPE-1 (TIMP-1) AS A CANCER MARKER AND POSTOPERATIVE MARKER FOR MINIMAL RESIDUAL DISEASE OR RECURRENT DISEASE IN PATIENTS WITH A PRIOR HISTORY OF CANCER

#892
20080255764
2008-10-16

Methods for the Diagnosis of Colorectal Cancer and Ovarian Cancer by the Measurement of Vitamin E-Related Metabolites

#893
20080248496
2008-10-09

Nuclear matrix protein alterations associated with colon cancer and colon metastasis to the liver, and uses thereof

#894
20080248039
2008-10-09

Antibodies Against Histone Modifications for Clinical Diagnosis and Prognosis of Cancer

#895
20080241131
2008-10-02

SPHKS as modifiers of the p53 pathway and methods of use

#896
20080241064
2008-10-02

COMPOSITIONS AND METHODS FOR IDENTIFYING AND TARGETING CANCER CELLS OF ALIMENTARY CANAL ORIGIN

#897
20080226664
2008-09-18

Method for inducing immune response to NY-CO-58

#898
20080219919
2008-09-11

Cytotoxicity mediation of cells evidencing surface expression of CD44

#899
20080207549
2008-08-28

GENES AND POLYPEPTIDES RELATING TO HEPATOCELLULAR OR COLORECTAL CARCINOMA

#900
20080199468
2008-08-21

Method For Diagnosing Colorectal Cancers